Reviewed and updated: November 12th, 2026
Massachusetts requires licensed cannabis products to undergo laboratory testing before being sold. These tests provide important information about THC potency and potential contaminants, but they cannot tell shoppers everything about the product inside the package.
In August 2026, the Massachusetts Cannabis Control Commission (CCC) published the results of a THC potency audit that raised new questions about label accuracy. By November, regulators were advancing additional testing requirements.
So how much can shoppers trust the numbers on cannabis labels? Understanding how products are sampled, tested, and labeled helps explain both the protections Massachusetts provides and their limitations.
What Massachusetts Cannabis Testing Is Designed to Do
Massachusetts requires cannabis products to be tested by licensed independent testing laboratories (ITLs). Testing requirements vary by product type, but generally include cannabinoid potency and screening for specified contaminants.
Depending on the product, laboratories analyze for:
Cannabinoids: Compounds such as THC, THCA, CBD, and CBDA.
Microbial contaminants: Including certain bacteria, mold, and yeast.
Heavy metals: Such as lead, arsenic, cadmium, and mercury.
Pesticide residues: Screening for substances prohibited under Massachusetts cannabis regulations.
Mycotoxins: Certain potentially harmful compounds produced by fungi.
Residual solvents: For products manufactured using solvent-based extraction methods.
The important distinction is that testing identifies and measures substances. Testing itself does not remove heavy metals, eliminate mold, or sterilize cannabis.
A product passing its required tests means the tested sample met the applicable compliance criteria. It does not necessarily mean every contaminant is absent, every individual flower is identical, or that the product has been evaluated for every possible concern.
The CCC's testing and sampling protocol establishes the underlying procedures for evaluating these products.
How One Sample Can Represent Up to 15 Pounds of Cannabis
One limitation of cannabis testing is that laboratories cannot individually test every flower that reaches a dispensary.
Massachusetts allows a post-harvest production batch of dried cannabis flower, shake, or trim to contain up to 15 pounds of material. A larger harvest can be separated into multiple batches, each associated with its own tracking and testing records.
This distinction matters. A 15-pound testing batch is not necessarily an entire harvest, and a testing result does not automatically describe every plant a cultivator harvested.
Instead, laboratories analyze representative material collected from the production batch. The accuracy of that result depends partly on how well the collected sample reflects the batch.
Who Collects the Sample and What Representative Means
Under the CCC's sampling protocol, the licensed business is responsible for collecting representative samples and documenting collection procedures.
That does not mean cultivators are permitted to simply select their most impressive-looking bud and submit it as representative of the entire batch.
The sampling protocol addresses how material must be collected according to factors such as quantity, physical form, and homogeneity, meaning how uniformly the material is distributed.
For material that cannot be treated as uniform, sampling procedures call for material from multiple locations or portions of the batch. Under the protocol's applicable mass-based sampling approach, a batch approaching 15 pounds falls into a category requiring at least ten subsamples.
Those subsamples help represent variations within the production batch.
Even with these safeguards, the final laboratory result is still based on collected material rather than every individual bud.
A well-designed sampling process reduces uncertainty, but it cannot eliminate natural differences between flowers.
What the CCC Found When It Tested Products From Store Shelves
On August 13, 2026, the Cannabis Control Commission published results from a potency audit that began in May.
Rather than relying exclusively on laboratory results submitted during production, the Commission selected finished products from retail dispensaries and medical treatment centers to verify THC label accuracy.
The audit included 63 cannabis flower products representing 62 producers.
Of those 63 products:
50 products fell within the Commission's accepted potency range.
13 products fell outside that range.
7 products had results within 2% of their labeled potency.
The Commission established an accepted audit range of 75% to 125% of the potency stated on the label.
For example, a flower product labeled at 20% total THC would have an accepted audit range of 15% to 25% total THC. This is a relative tolerance of 25%, not an allowance of 25 percentage points in either direction.
In a published shelf-audit notice, the Commission described taking a product available to consumers and submitting it as a blind sample to the laboratory responsible for its original test.
The laboratory was directed to homogenize the material and analyze three randomly selected subsamples. Their average was used to evaluate the labeled potency.
Blind retesting provides an additional check on the testing results associated with products already being sold.
For products outside the accepted range, the CCC identified corrective options including relabeling, additional testing, repurposing, or destruction, depending on the circumstances.
The CCC's August 13 announcement provides the official results.
What the Results Show and What They Cannot Explain
Thirteen of the 63 audited products fell outside the accepted potency range. That is approximately 21% of the products selected for this particular audit.
It would be misleading to conclude that 21% of all Massachusetts cannabis products are mislabeled. The audit was a targeted compliance exercise, not a statistically representative survey of every product sold statewide.
The findings also do not establish one universal explanation for the discrepancies.
Potential sources of variation include differences in plant material, sampling, laboratory measurement, and changes during storage. But identifying those possibilities is different from proving what caused a particular product's result.
Likewise, the audit does not demonstrate that Massachusetts' 15-pound batch limit caused the discrepancies.
What it does establish is that independent checks of retail products can identify meaningful differences between advertised THC potency and subsequent laboratory measurements.
Can Remediated Cannabis Be Sold in Massachusetts?
Yes, certain cannabis products that initially fail testing can become eligible for sale after approved corrective procedures and successful follow-up testing.
Massachusetts regulations distinguish between retesting a failed sample, remediating material, and disposing of material that cannot meet compliance requirements.
Remediation is not automatically permitted for every type of failure.
Where remediation is permitted, the product must undergo required testing before it can be released for sale. The regulations also limit remediation attempts, with disposal required when the applicable conditions cannot be satisfied.
A passing result following remediation establishes that the material met the relevant requirements during subsequent testing. It does not mean the original failure never occurred.
Sanitization Before Testing vs Remediation After Failure
These terms sound similar, but the distinction is important.
Sanitization refers to treatment performed before compliance testing, intended to reduce microbiological contaminants in a batch.
Remediation refers to treatment performed after a product has failed a relevant compliance test.
Examples of treatments that may require reporting include irradiation and ozone treatment.
Under the CCC's Administrative Order No. 5, which took effect June 16, 2025, licensees must disclose relevant sanitization and remediation processes to their testing laboratory.
The treatment must apply to the appropriate source production batch, not simply the small sample submitted for laboratory testing.
If material undergoes sanitization and later requires remediation, both processes must be reported.
The CCC's Administrative Order No. 5 FAQ explains these distinctions and the associated reporting requirements.
COA Disclosure vs Consumer Package Labels
A Certificate of Analysis, commonly called a COA, is a laboratory document containing testing information associated with a particular product sample.
A COA can provide more detail than the package label, including analytical results, laboratory information, and required treatment disclosures.
Administrative Order No. 5 requires qualifying sanitization and remediation information to be reported to laboratories and included on applicable COAs, with information also recorded in the state's Metrc tracking system.
That does not mean every detail in a COA must currently appear on the retail package.
The distinction is especially important because the CCC's November 2026 regulatory proposal includes new consumer-facing labeling requirements for sanitized and remediated products. Those requirements are proposals, not yet effective rules.
Consumers can request the COA associated with a product through their retailer or the Commission. The most useful document is the report connected to the specific batch being purchased, not simply another batch of the same strain.
What Complaints and Enforcement Records Reveal
Questions about cannabis testing are not limited to THC potency. They also involve laboratory reporting, contamination results, and regulatory oversight.
Consumer complaints can raise legitimate concerns. But an allegation is not the same as a confirmed violation. Public enforcement records provide a more reliable way to understand what regulators investigated and what actions they took.
One significant example involves Assured Testing Laboratories in Tyngsborough, Massachusetts.
On June 30, 2025, the CCC issued a summary suspension order involving the laboratory.
On August 14, 2025, the Commission approved a stipulated agreement that included a $300,000 fine, a 12-month suspension of the laboratory's then-CEO, a 24-month probationary period, an independent audit, and additional quality-control requirements.
The agreement recorded Commission findings concerning the reporting of microbial and other compliance-test results. Among the disputed findings were failures to properly report certain microbial results and instances where results were recorded as zero or not tested.
Importantly, the agreement states that Assured Testing Laboratories neither admitted nor denied the Commission's specified findings. The settlement was binding, but it was not an admission of liability.
The matter involved subsequent amendments, including an order dated February 12, 2026.
These actions demonstrate how the Commission can investigate laboratory conduct and impose oversight and corrective requirements. They do not establish that every laboratory in Massachusetts has engaged in similar practices.
The CCC's public enforcement records and its August 14, 2025 stipulated agreement provide the documentation.
Consumers who suspect a product has been mislabeled or presents a safety concern should retain the packaging, batch number, receipt, and relevant photographs before contacting the retailer or Commission.
Why the Highest THC Percentage Is Not a Quality Guarantee
THC potency is useful information, but it is only one characteristic of cannabis.
A flower testing at 30% THC is not automatically better than one testing at 20%. The numbers describe cannabinoid concentration, not an overall quality ranking.
Consider two batches of the same cultivar. One may have a higher THC result, while the other has been more carefully dried, cured, and stored.
Those differences can influence aroma, moisture, texture, and the overall smoking experience, none of which are fully captured by THC percentage.
Terpenes add another layer of information. These aromatic compounds help create the recognizable citrus, pine, floral, herbal, and fuel-like characteristics associated with different cannabis varieties.
Understanding THC percentage and terpenes can be more useful than choosing a product based exclusively on its largest cannabinoid number.
Even terpene information has limitations. A particular terpene profile does not guarantee a specific effect, and individual experiences can differ.
For shoppers, the better question is not necessarily which product has the most THC. It is which product offers the characteristics, format, and experience they are looking for. Although high testing numbers look intriguing, cannabis is a complex plant with many layers.
The strain with attributes that seem appealing to you is normally the best strain to go with. When selecting buds, pre-rolls, or even vapes and edibles, go with the cultivar that aligns with your ideal outcome. Don’t judge every plant solely by the number on it’s label.
How to Read a Cannabis Label and Ask Better Questions
A cannabis label contains several pieces of information worth examining before making a purchase.
Start with the cannabinoid numbers.
THCA vs THC: THCA is the naturally occurring acidic precursor to THC. Heating converts some THCA into THC, but that conversion is not perfectly efficient.
For products intended for combustion, Massachusetts requires total THC to be calculated using:
Total THC = Delta-9 THC + (THCA × 0.877)
This is a calculation of potential THC content, not a prediction of how much THC a person will absorb.
TAC: Total active cannabinoids generally refers to a broader cannabinoid measurement. It should not be confused with total THC, and the compounds included can depend on the reporting method.
Batch identification: Products should contain identifying information connecting them to the appropriate production and testing records.
Testing and packaging dates: These dates can provide context about when the product was evaluated and how long it has been packaged, although they do not independently establish freshness.
Product quantity: For flower, compare the weight of the product. For THC edibles, pay attention to milligrams per serving versus total milligrams in the package.
Before purchasing, consider asking:
Is the displayed number total THC, THCA, or TAC?
Can I see the COA for this particular batch?
When was the product tested and packaged?
Was the product sanitized or remediated?
What do we know about its aroma, freshness, and storage?
Is the higher THC percentage actually relevant to what I want?
For anyone visiting a dispensary for the first time, knowing what to expect and which questions to ask can make shopping feel a lot more approachable. The goal is not to turn every cannabis purchase into a laboratory investigation. It is to understand what the available information tells you and where additional questions are worthwhile.
Massachusetts cannabis testing provides important safeguards, but no single laboratory result tells the whole story. THC percentages are useful estimates of potency, not guarantees of an identical experience or measures of overall quality. Likewise, passing contaminant testing means a product met the applicable standards, not that it is completely free of microorganisms or other substances.
The CCC's 2026 potency audit showed why independent verification matters, while proposed regulatory changes aim to improve testing consistency and make more information available to consumers. For shoppers, the best approach is to look beyond the THC number. Understanding testing dates, batch information, product history, and the limitations of laboratory results makes it easier to ask informed questions and choose cannabis with greater confidence.
What Massachusetts Is Changing About Cannabis Testing
Massachusetts has made several important changes to cannabis testing oversight in recent years.
In March 2024, the CCC clarified cannabinoid reporting requirements, including the calculation of total THC and reporting results without adjusting them to a dry-weight basis.
In June 2025, Administrative Order No. 5 strengthened laboratory documentation and disclosure requirements involving COAs, sanitization, and remediation.
In May 2026, the Commission began its THC potency shelf audit, publishing the findings that August.
The regulatory process continued through the fall.
On November 12, 2026, the CCC announced that it had advanced a new draft testing framework intended to consolidate and modernize requirements under a proposed 935 CMR 503.000.
The proposal includes:
Requiring compliance testing before business-to-business and consumer sales.
Moving toward targeted testing for specified microbial organisms of public-health concern.
Establishing additional procedures for laboratories to confirm initial test failures.
Requiring consumer package labels to identify sanitized or remediated products.
Creating a more unified set of cannabis testing regulations.
The Commission also indicated that further work on sampling and pesticide testing is anticipated in 2027.
These are proposed changes, not requirements already in effect.
As of November 13, 2026, the CCC expects further regulatory review, public comment, and final promulgation in 2027. The proposed testing framework would become effective six months after promulgation, if adopted as outlined.
The CCC's November 12 announcement details the proposals and next steps.
For Massachusetts shoppers, the direction is clear: regulators are pursuing more consistent testing, greater transparency, and stronger verification of the information appearing on cannabis products.
Massachusetts Cannabis Testing FAQs
Does passing a laboratory test mean cannabis is free of mold or contaminants?
No. A passing result means the tested sample met the applicable requirements. It does not mean the cannabis is sterile, that every microorganism is absent, or that every possible contaminant has been evaluated.
Is every cannabis bud in Massachusetts tested?
No. Testing uses representative samples from defined production batches. Sampling procedures are intended to account for variation within the batch, but individual buds are not all tested separately.
How accurate are THC percentages on Massachusetts cannabis labels?
THC percentages are based on laboratory results, but natural variation and measurement limitations can create differences. In its 2026 flower shelf audit, the CCC accepted results within 75% to 125% of labeled potency. Thirteen of the 63 audited products fell outside that range.
Can previously failed cannabis be sold after remediation?
Certain products can become eligible for sale after permitted remediation and successful follow-up testing. The rules depend on the reason for failure, and not every type of contamination is eligible for remediation.
Can consumers find out if cannabis was sanitized or remediated?
Consumers can request a batch-specific COA, which may contain required sanitization or remediation disclosures. The CCC is also proposing consumer package-label disclosures, but those additional requirements were not yet effective as of November 13, 2026.
Does higher THC mean better cannabis?
Not necessarily. THC is one measurement of potency. It does not establish freshness, proper curing, aroma, handling quality, or whether someone will prefer a product.
Can I request a cannabis product's Certificate of Analysis?
Yes. Ask the retailer for the COA associated with the specific production batch. Matching the batch is important because different batches of the same strain can have different results.
